Seres Therapeutics (MCRB) Tops Q3 EPS by 9c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: MCRB) | Delayed: 1.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $44.51 | |||
| Open | $1.96 | 52 Week Low | $8.05 | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.96 | EPS | $0.00 | |||
| Volume | 4,702 | |||||
